Sydney Colton Begins WNBA Playoffs Sunday

1,167 Views | 2 Replies | Last: 4 yr ago by coldmoose
Rudybryan
How long do you want to ignore this user?
Sydney Colson Begins WNBA Playoffs Sunday
Sep 13, 2019


By:
Texas A&M Athletics Communications

LAS VEGAS, Nevada Texas A&M legend Sydney Colson has been named to a WNBA Playoff roster for the second consecutive year, as she and the Las Vegas Aces take on Chicago to begin their 2019 postseason Sunday, September 15 at the Thomas & Mack Center at 4 p.m. on ESPN2.

Colson, who signed as a free agent with Las Vegas on May 13, has brought veteran leadership and high-efficiency shooting to the team. She has played 33 games, averaging 3.3 points and 1.8 assists per game, while also shooting 44.0 percent from the field, 45.0 percent on 3-pointers, and 81.8 from the free-throw line.

She had a career-high 17 points against Washington on July 13, and posted a season-high five assists twice. Colson helped the Aces earn a bye into the single-elimination Second Round, and with a win on Sunday, would face Washington or Connecticut in the best-of-five WNBA Semifinals that begin September 17.

Last season, Colson made the postseason roster for Minnesota, but did not play as the Lynx lost in the single-elimination first round.

During her four seasons with Texas A&M, Colson averaged 6.2 points and 3.7 assists. In her last season of 2010-11, she put up career highs in all categories, averaging 8.0 points, 6.1 assists, and 2.4 steals, helping the Aggies win the National Championship.
Rudybryan
BigJim49 AustinNowDallas
How long do you want to ignore this user?
alamoaggie64
How long do you want to ignore this user?
AG
Her stats don't tell full story of what she meant to our team
coldmoose
How long do you want to ignore this user?
Close loss in game 1 of the semi-finals. I hope the next one works out for the Aces. Sydney has been such a positive force for that organization.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.